from24/7 Wall St.3 weeks agoThis Former Meme Stock, Down 93%, is a High-Upside Buy Right NowModerna's stock may rebound as it transitions from COVID vaccines to a diverse mRNA product pipeline by 2026.
US newsfromBoston.com4 months agoQ&A: Nobel Prize-winning researcher and BU grad discusses vaccine development, vaccine hesitancy, and preparing for another pandemicDrew Weissman and Katalin Karikó were awarded the 2023 Nobel Prize for their groundbreaking mRNA research crucial for COVID-19 vaccine development.
OMG sciencefromwww.nytimes.com4 months agoOpinion | DOGE Needs a Different Playbook for ScienceKatalin Kariko's determination led to mRNA vaccine breakthroughs despite severe funding and institutional challenges.